A new survival score for patients with brain metastases who received whole-brain radiotherapy (WBRT) alone

Since the 6-month survival rates in the validation group were very similar to the test group, this new score (WBRT-30) appears valid and reproducible. It can help making treatment choices and stratifying patients in future trials.